Top compounds associated with response to TPGS2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA PD318088 CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.13 9e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA lapatinib GDSC1000 pan-cancer AAC -0.17 0.0005
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 0.0006
Download CSV